LIVI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.061
AS - Asia 666
EU - Europa 470
SA - Sud America 134
Continente sconosciuto - Info sul continente non disponibili 27
AF - Africa 14
OC - Oceania 2
Totale 2.374
Nazione #
US - Stati Uniti d'America 1.009
SG - Singapore 243
CN - Cina 132
BR - Brasile 108
HK - Hong Kong 93
BE - Belgio 91
IT - Italia 76
VN - Vietnam 63
FR - Francia 60
DE - Germania 52
FI - Finlandia 42
GB - Regno Unito 42
CA - Canada 38
TR - Turchia 29
BD - Bangladesh 24
IE - Irlanda 20
RU - Federazione Russa 20
IN - India 16
UA - Ucraina 15
IQ - Iraq 14
ES - Italia 12
JP - Giappone 12
MX - Messico 10
NL - Olanda 10
PL - Polonia 10
AR - Argentina 9
SE - Svezia 8
ZA - Sudafrica 8
ID - Indonesia 7
UZ - Uzbekistan 5
VE - Venezuela 5
AT - Austria 4
DZ - Algeria 4
PK - Pakistan 4
CL - Cile 3
JM - Giamaica 3
LK - Sri Lanka 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 2.348
Città #
Singapore 119
Ashburn 113
Hong Kong 90
Leuven 90
Fairfield 70
San Jose 54
New York 51
Dallas 44
The Dalles 43
Los Angeles 42
Cambridge 38
Helsinki 37
Houston 35
Beijing 33
Princeton 32
Santa Clara 28
Lauterbourg 26
Woodbridge 24
Istanbul 22
Council Bluffs 20
Seattle 20
Ho Chi Minh City 19
Dublin 18
Jacksonville 18
São Paulo 18
Wilmington 18
Hanoi 16
Columbus 15
Chandler 14
Brescia 13
Frankfurt am Main 12
Munich 12
Shanghai 12
Baghdad 10
Des Moines 10
London 10
Redondo Beach 10
Toronto 10
Boston 9
Brooklyn 9
San Diego 9
Tokyo 9
Warsaw 9
Barcelona 8
Johannesburg 8
Ann Arbor 7
Montreal 7
Orem 7
San Francisco 7
Buffalo 6
Chicago 6
Moscow 6
Jakarta 5
Poplar 5
Romola 5
Tashkent 5
Atlanta 4
Chennai 4
Denver 4
Dong Ket 4
Haiphong 4
Hanover 4
Roubaix 4
Tlemcen 4
Vancouver 4
Amsterdam 3
Ankara 3
Bergamo 3
Caracas 3
Charlotte 3
Colombo 3
Da Nang 3
Düsseldorf 3
Florence 3
Giugliano in Campania 3
Guangzhou 3
Madrid 3
New Delhi 3
Pescara 3
Povegliano Veronese 3
Riyadh 3
Rome 3
Salt Lake City 3
Santiago 3
Turku 3
Amman 2
Araguaína 2
Belo Horizonte 2
Boardman 2
Brno 2
Burnaby 2
Campinas 2
Grand Bourg 2
Greenville 2
Guarulhos 2
Hefei 2
Hounslow 2
Islington 2
Jersey City 2
Karachi 2
Totale 1.519
Nome #
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 284
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations 169
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 132
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 112
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 111
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 103
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) consensus conference on sarcoma interventional radiotherapy (brachytherapy) endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) 98
Letter to the Editor 92
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 90
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 87
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 86
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 86
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 85
Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology) 85
Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies 84
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START) 82
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: A view of the nation's young oncologists 82
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus 81
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 77
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence 75
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 70
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort 69
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study 65
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 57
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial 6
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial 6
Totale 2.374
Categoria #
all - tutte 14.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022111 0 22 3 3 1 18 5 4 8 6 7 34
2022/2023106 18 0 2 4 3 19 2 17 20 0 11 10
2023/2024210 18 9 25 3 9 47 10 0 44 4 10 31
2024/2025431 0 2 7 58 31 40 25 24 53 41 112 38
2025/20261.196 118 141 111 181 95 74 158 58 90 91 38 41
2026/202790 39 51 0 0 0 0 0 0 0 0 0 0
Totale 2.374